>FASTA: weekly short reads of the global biotech ecosystem | Papers and patents, acquisitions and bankruptcies, biotech philosophy | Read in under 5 min | Follow on LinkedIn, X, YouTube, and Instagram! | Versión en Español

Pilgrim is proud to sponsor >FASTA! We’re developing the next generation of military medicine to meet the operational demands of modern warfare—moving beyond theory and bringing biotechnology from the benchtop to the battlefield.

1/10: Our sponsor cut open his leg and raised $4.3M

2/10: Why LuxBio sells glow sticks to NASA

3/10: Geltor is back in the game with consumer peptides

4/10: Prepare for more biotech defense bills

5/10: A keto cure to schizophrenia?

6/10: Evolved CRISPR-associated transposases (CasTs)

7/10: Profluent's Open CRISPR-1 outperforms baseline

8/10: Strand Tx raised $153M

9/10: Josie Zayner’s story

10/10: Stop playing God. Become one.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.biopunk.life/subscribe